Trichomoniasis epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 33: | Line 33: | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Gynecology]] | [[Category:Gynecology]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Revision as of 16:17, 26 January 2016
|
Trichomoniasis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Trichomoniasis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Trichomoniasis epidemiology and demographics |
|
Risk calculators and risk factors for Trichomoniasis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2]
Overview
Epidemiology and Demographics
Trichomoniasis is the most common curable STD in young, sexually active women. An estimated 7.4 million new cases occur each year in women and men. The relative standard error for trichomoniasis estimates range from 7.5% to 13% and for other vaginitis estimates range from 16% to 30%.
Trichomonas vaginalis, a flagellate, is the most common pathogenic protozoan of humans in industrialized countries. However, it occurs worldwide.
Prevalence
Trichomoniasis and other vaginal infections in women — Initial visits to physicians' offices: United States, 1966–2005:[1][2]
Incidence
Age
Gender
Race
Trichomoniasis usually affects African American individuals. Caucasian individuals are less likely to develop trichomoniasis. In the United States, the highest prevalence of trichomonas infection in US women is seen among African-Americans with rates ranging from 13–51%.[3]
References
- ↑ "STD Facts - Trichomoniasis". Retrieved 2012-12-27.
- ↑ "DPDx - Trichomoniasis". Retrieved 2012-12-27.
- ↑ Kissinger P (2015). "Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues". BMC Infect Dis. 15: 307. doi:10.1186/s12879-015-1055-0. PMC 4525749. PMID 26242185.